Table 2.
Characteristics | Proportion or mean | |
---|---|---|
Household-level | ||
Number of households enrolled | 3,027 | |
Household net ownership, % (n) | Yes | 95.8 (2,902) |
Household net access, % (n) | Yes | 55.9 (1,691) |
Population net access, % (95% CI) | Yes | 79.5 (78.9–80.1) |
Number of nets (any type) in the household | Mean (±SD) | 2.5 (±1.3) |
Number of LLIN in the household | Mean (±SD) | 2.3 (±1.3) |
Individual-level | ||
Number of participants enrolled | 4,441 | |
Number of participants enrolled with a net | 4,088 | |
Number of participants enrolled with an LLIN | 3,949 | |
Origin of LLIN, % (n) | National campaign (2017) | 91.0 (3,595) |
Healthcare facility (ANC) | 6.4 (251) | |
Healthcare facility (EPI) | 1.6 (65) | |
Public market | 0.4 (16) | |
Other | 0.6 (22) | |
Proportion of LLIN observed, % (n) | Yes | 99.0 (3,910) |
Type of LLIN, % (n) | PermaNet 2.0 | 64.3 (2,489) |
Dawa plus | 9.6 (374) | |
Olyset Net | 7.0 (271) | |
Duranet | 1.4 (53) | |
Yorkool | 0.5 (21) | |
Other* | 5.7 (221) | |
Unknown | 11.4 (443) | |
Duration usage of LLIN, % (n) | ≤ 1 year | 7.2 (286) |
2 years | 64.3 (2,540) | |
3 years | 21.1 (833) | |
> 3 years | 7.3 (290) | |
LLIN conditions, % (n) | Good | 18.9 (732) |
Average | 43.2 (1,671) | |
Poor | 37.9 (1,468) | |
Population LLIN use, % (n) | Yes | 95.8 (3,782) |
Net usage the week before the visit, % (n) | All nights | 88.4 (3,490) |
Most of the nights | 8,6 (338) | |
Few nights | 3.1 (121) |
ANC = antenatal care visit; EPI = expended program immunization; LLIN = long-lasting insecticidal net; SD = standard deviation.
Most important other types of bed nets observed were impregnated by deltamethrin (88.2%, 195/221).